Medication info
Olmesartan Medoxomil 20 mg Tablets

Olmesartan Medoxomil 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100798 · Approved 2011.02.21 · Insurance code 653402240

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure remains high without a specific cause. This medication helps to control essential hypertension, lower blood pressure, and reduce the risk of cardiovascular diseases. Regular use contributes to stabilizing blood pressure and preventing complications. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

Safety and efficacy in children have not been established.

Precautions

This drug can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so treatment must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients allergic to any of its ingredients, patients undergoing renal dialysis, patients with severe liver impairment, patients with biliary obstruction, and certain genetically predisposed patients with lactose intolerance. Special caution should be exercised in patients with low blood volume or low sodium, as hypotension may occur, and patients with impaired renal function or kidney transplant recipients should have their renal function and potassium levels monitored regularly through blood tests. This medication carries a risk of hyperkalemia, so patients with heart failure or impaired renal function should carefully monitor potassium levels in the blood. Patients with aortic or mitral valve stenosis and obstructive cardiomyopathy need special caution when taking this medication. Dizziness may occur during treatment, so it is advisable to avoid high-altitude tasks or operating hazardous machinery while on this medication. Common side effects may include dizziness, headache, abdominal pain, nausea, palpitations, and rash, while rare side effects can include angioedema or liver dysfunction. If chronic diarrhea and weight loss occur, discontinue use and consult a physician. This medication may interact with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so it is crucial to inform healthcare providers of any other medications being taken. Pregnant or breastfeeding women should avoid this medication, especially during pregnancy, as it could pose risks to the fetus, requiring immediate cessation of use. Safety in children has not been established, and caution is advised in the elderly as drug concentration in the body may increase. In case of overdose, symptoms like hypotension or palpitations may occur, requiring immediate medical attention. While this medication is known to have a low risk of carcinogenic or genotoxic effects with prolonged use, it is important to consult a physician before and after treatment.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • elevated blood pressure
  • epistaxis
  • asthma
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 25 degrees Celsius at room temperature. Proper storage helps maintain the potency of the medication for an extended period.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.